In Vitro Effects of Plasma Collected From Rats Administered Naftopidil on Whole Urinary Bladder Preparation Isolated From Rats
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Alpha-1-adrenoceptor blockers (e.g., naftopidil) are prescribed for the treatment of male lower urinary tract symptoms. Although the mechanism of action of naftopidil has been studied in various organs, that in the urinary bladder remains unknown. To clarify the direct effects of naftopidil on this organ, activities were assessed in the isolated rat whole urinary bladder. Methods: A total of 30 female rats were used. In Experiment 1, bladder activity was measured during a cumulative administration of 2.5–75μM naftopidil (n=7). In Experiment 2, rats were divided into 2 groups: control (n=10) and naftopidil (5 mg/ animal/day, oral gavage, once-daily for 2 weeks) (n=13). After the treatment period, plasma was obtained from each rat. The urinary bladders were harvested from the control rats. Isovolumetric rhythmic bladder contractions were induced at above the threshold volume, and intravesical pressure was recorded. Control plasma was added to the organ bath; after subsequent wash-out, plasma collected from rats administered naftopidil was added. In Experiment 3, the plasma levels of monoamines and amino acids were quantified using the individual plasma prepared in the Experiment 2. Results: Cumulative dosing with naftopidil did not change the interval between spontaneous contractions compared to the interval at baseline. After adding control plasma, the interval was shortened compared to the baseline (P=0.008). The plasma collected from rats administered naftopidil suppressed the shortening of the interval compared to the control plasma (P=0.041). Naftopidil resulted in a decrease in the level of noradrenaline (P=0.009) and an increase in that of glycine (P=0.014). Conclusions: Although naftopidil did not directly act on the interval between spontaneous contractions of the urinary bladder, the plasma collected from rats administered naftopidil, with changing levels of monoamines and amino acids, may suppressed shortening the interval.
Abstract
Purpose: Alpha-1-adrenoceptor blockers (e.g., naftopidil) are prescribed for the treatment of male lower urinary tract symptoms. Although the mechanism of action of naftopidil has been studied in various organs, that in the urinary bladder remains unknown. To clarify the direct effects of naftopidil on this organ, activities were assessed in the isolated rat whole urinary bladder. Methods: A total of 30 female rats were used. In Experiment 1, bladder activity was measured during a cumulative administration of 2.5–75μM naftopidil (n=7). In Experiment 2, rats were divided into 2 groups: control (n=10) and naftopidil (5 mg/ animal/day, oral gavage, once-daily for 2 weeks) (n=13). After the treatment period, plasma was obtained from each rat. The urinary bladders were harvested from the control rats. Isovolumetric rhythmic bladder contractions were induced at above the threshold volume, and intravesical pressure was recorded. Control plasma was added to the organ bath; after subsequent wash-out, plasma collected from rats administered naftopidil was added. In Experiment 3, the plasma levels of monoamines and amino acids were quantified using the individual plasma prepared in the Experiment 2. Results: Cumulative dosing with naftopidil did not change the interval between spontaneous contractions compared to the interval at baseline. After adding control plasma, the interval was shortened compared to the baseline (P=0.008). The plasma collected from rats administered naftopidil suppressed the shortening of the interval compared to the control plasma (P=0.041). Naftopidil resulted in a decrease in the level of noradrenaline (P=0.009) and an increase in that of glycine (P=0.014). Conclusions: Although naftopidil did not directly act on the interval between spontaneous contractions of the urinary bladder, the plasma collected from rats administered naftopidil, with changing levels of monoamines and amino acids, may suppressed shortening the interval.
참고문헌 (28)
- Abrams P, "The standardisation of terminology of lower urinary tract function : report from the Standardisation Sub-committee of the International Continence Society", Neurourol Urodyn, 21, pp.167~178 (2002)
- Apostolidis A, "Gender and age differences in the perception of bother and health care seeking for lower urinary tract symptoms : results from the hospitalised and outpatients’ profile and expectations study", Eur Urol, 56, pp.937~947 (2009)
- Lee SW, "Importance of relieving the most bothersome symptom for improving quality of life in male patients with lower urinary tract symptoms", Urology, 80, pp.684~687 (2012)
- Majima T, "Effect of naftopidil on bladder microcirculation in a rat model of bladder outlet obstruction", Low Urin Tract Symptoms, 9, pp.111~116 (2017)
- Sugaya K, "Relationship of blood flow in the common iliac vein to lower urinary tract disease", J Med Ultrason(2001), 46, pp.223~229 (2019)
- Sugaya K, "Pelvic congestion syndrome caused by inferior vena cava reflux", Int J Urol, 7, pp.157~159 (2000)
- Sugaya K, "Pelvic venous congestion induces lower urinary tract dysfunction in rats", Biomed Res, 39, pp.269~277 (2018)
- Ismaeel A, "Oxidative stress and arterial dysfunction in peripheral artery disease", Antioxidants (Basel), 7(10), pp.E145~ (2018)[DOI]
- Gotoh M, "Comparison of tamsulosin and naftopidil for efficacy and safety in the treatment of benign prostatic hyperplasia : a randomized controlled trial", BJU Int, 96, pp.581~586 (2005)
- Takei R, "Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors", Jpn J Pharmacol, 79, pp.447~454 (1999)
- Sugaya K, "Effects of propiverine and naftopidil on the urinary ATP level and bladder activity after bladder stimulation in rats", Neurosci Lett, 429, pp.142~146 (2007)
- Sugaya K, "Spinal mechanism of micturition reflex inhibition by naftopidil in rats", Life Sci, 116, pp.106~111 (2014)
- Yokoyama O, "Improvement of bladder storage function by alpha1-blocker depends on the suppression of C-fiber afferent activity in rats", Neurourol Urodyn, 25, pp.461~467 (2006)
- Sugaya K, "Naftopidil improves locomotor activity and urinary frequency in rats with pelvic venous congestion", Biomed Res, 37, pp.221~226 (2016)
- Sugaya K, "Influence of temperature on activity of the isolated whole bladder preparation of neonatal and adult rats", Am J Physiol Regul Integr Comp Physiol, 278, pp.R238~46 (2000)
- Mitsui T, "Correlation between high temperature dependence of smooth muscle myosin light chain phosphatase activity and muscle relaxation rate", J Biol Chem, 269, pp.5842~5848 (1994)
- Liu X, "Enantiospecific determination of naftopidil by RRLC-MS", MS reveals stereoselective pharmacokinetics and tissue distributions in rats, 2015, pp.112, 147~154
- Akino H, "α1-Blocker inhibits non-voiding contractions and decreases the level of intravesical prostaglandin E2 in rats with partial bladder outlet obstruction", Int J Urol, 26, pp.924~930 (2019)
- Sakai T, "Naftopidil inhibits 5-hydroxytryptamine-induced bladder contraction in rats", Eur J Pharmacol, 700, pp.194~200 (2013)
- Sadananda P, "A functional analysis of the influence of β3-adrenoceptors on the rat micturition cycle", J Pharmacol Exp Ther, 347, pp.506~515 (2013)
- Nishijima S, "Serum amino acids as indicators of cerebrospinal neuronal activity in patients with micturition disorders", Int J Urol, 13, pp.1479~1483 (2006)
- Andersson KE, "Nitric oxide synthase and the lower urinary tract : possible implications for physiology and pathophysiology", Scand J Urol Nephrol Suppl, 175, pp.43~53 (1995)
- Knowles RG, "Nitric oxide synthases in mammals", Biochem J, 298(Pt 2), pp.249~258 (1994)
- Mitsui T, "Metabolomics approach to male lower urinary tract symptoms : identification of possible biomarkers and potential targets for new treatments", J Urol, 199, pp.1312~1318 (2018)
- Pintér E, "Plasma extravasation in the skin and pelvic organs evoked by antidromic stimulation of the lumbosacral dorsal roots of the rat", Neuroscience, 68, pp.603~614 (1995)
- Andrews PV, "NK-1 receptor mediation of neurogenic plasma extravasation in rat skin", Br J Pharmacol, 97, pp.1232~1238 (1989)
- Nishijima S, "High-dose tranilast administration to rats creates interstitial cystitis-like symptoms with increased vascular permeability", Life Sci, 26(93), pp.897~903 (2013)
- Saito M, "Age-related changes in the response of the rat urinary bladder to neurotransmitters", Neurourol Urodyn, 12, pp.191~200 (1993)